ULRICH BROECKEL, MD - FOUNDER & CHIEF EXECUTIVE OFFICER
Ulrich Broeckel, MD, is a leading clinician scientist with over 20 years of experience in genetics and genomics and more than 10 years of experience in clinical diagnostics. He is an expert in translational pharmacogenomic research, and is a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the NIH initiatives on clinical pharmacogenomics. Dr. Broeckel serves as Professor of Pediatrics, Section Chief of Genomic Pediatrics, and Director of the Individualized Medicine Institute at the Medical College of Wisconsin.
Gunter Scharer, MD - Chief Medical Officer
Gunter Scharer, MD, is a board-certified medical geneticist with over 15 years of clinical and laboratory experience. He is board certified in Clinical Genetics, Clinical Molecular Genetics, and Medical Biochemical Genetics, and licensed to practice in several states (CA, CO, MN, WI). Prior to joining RPRD Diagnostics, from 2015-2017, Dr. Scharer was the director of the Department of Medical Genetics and Genomics at Children's Minnesota and Adjunct Associate Professor in Pediatrics at the Medical College of Wisconsin.
Lina Li, PhD MBA – Director, Marketing and Business Development
Lina Li has over 10 years of experience in market development and strategic planning across the biotech sector. Prior to joining RPRD Diagnostics she developed and executed a number of successful product launches, and served as strategist for a leading healthcare provider.
Rachel Lorier - Director, Laboratory Operations
Rachel Lorier has over 10 years of experience developing the infrastructure and managing the operation of two clinical laboratories involved in cytogenetic and pharmacogenetic testing. She has many years of experience in research and clinical testing.
Andrea Matter - Director, Regulatory Affairs
Andrea Matter has over 10 years of experience in clinical diagnostics, as well as FDA compliance. She has written extensive GMP documentation for NADA submission, as well as developed the regulatory infrastructure for two clinical laboratories under CAP/CLIA regulation.
Amy Turner - Director, Research & Development
Amy Turner has over 10 years of experience in complex molecular test development, and over five years of experience supervising a clinical laboratory. She has developed a wide range of experimental methodologies, from detection of complex genetic variation, to exosomal biomarker screening.